Diametric Capital »

Enliven Therapeutics shares owned by Diametric Capital

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Diametric Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $515k 29k 17.59